Resistance of mature T cells to oncogene transformation.
about
A transposon and transposase system for human applicationGenetic engineering of T cells for adoptive immunotherapyChimeric Antigen Receptors Modified T-Cells for Cancer TherapyCAR T Cell Therapy: A Game Changer in Cancer TreatmentCARs in chronic lymphocytic leukemia -- ready to driveProgress and prospects for engineered T cell therapiesGenetically modified T cells for the treatment of malignant diseaseGene therapy on the moveRetroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectivesEngineering T Cells to Functionally Cure HIV-1 InfectionT cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies.Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalance.Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesis.High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion.Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases.Clonal competition in BcrAbl-driven leukemia: how transplantations can accelerate clonal conversion.Immunotherapy: opportunities, risks and future perspectivesThe basic principles of chimeric antigen receptor design.Gene therapy strategies: can we eradicate HIV?Lineage- and stage-restricted lentiviral vectors for the gene therapy of chronic granulomatous disease.Thymidine kinase suicide gene-mediated ganciclovir ablation of autologous gene-modified rhesus hematopoiesis.The human application of gene therapy to re-program T-cell specificity using chimeric antigen receptorsAn efficient low cost method for gene transfer to T lymphocytesIntegration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cellFunctional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies.Contributions of gene marking to cell and gene therapies.Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALLNCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic maGenome-wide Profiling Reveals Remarkable Parallels Between Insertion Site Selection Properties of the MLV Retrovirus and the piggyBac Transposon in Primary Human CD4(+) T Cells.Engineering lymphocyte subsets: tools, trials and tribulationsTowards a Safer, More Randomized Lentiviral Vector Integration Profile Exploring Artificial LEDGF Chimeras.Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIVAlpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing.Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy.Engineered T cells for anti-cancer therapy.Lmo2 induces hematopoietic stem cell-like features in T-cell progenitor cells prior to leukemiaMature T-cell lymphomagenesis induced by retroviral insertional activation of Janus kinase 1.T lymphocytes are not immune
P2860
Q24630047-C1951BB0-9F91-4294-92A3-53B249096934Q24642718-B436F004-5DCE-462C-8A9F-523EDBFA803CQ26773309-52F9DE2D-AFA6-4122-88DC-ADF5E163E31DQ26822769-B27AF18D-FB1A-4869-B647-F58E324153ABQ26830526-AE59003B-16ED-4ABE-8327-B57ACF17EF2FQ26852923-E99B3FD3-F4E0-4DA2-9F94-FC2BD2D21023Q26860657-7E98A53B-7472-416F-B8BA-4FC26ECF1974Q27007012-BB6DA25D-B889-41D3-A6D5-5D17B8A01F48Q28074002-EBB195BE-9401-4EC3-A847-3ED650CF620AQ28086801-537DC53D-D460-4EF5-8181-B8D94227C1B0Q33530527-CB3C4C4E-A90D-417A-BF4B-41B7067EAF73Q33712953-2AB038A5-1B01-4149-A262-EE35E2DA5795Q33713961-4D0E2C3F-D716-4EF6-B41D-C5B709A90BC8Q33784684-96667047-5301-437E-BA04-F71AA8716A10Q33886716-5199940E-8440-40D3-B69B-67F677A98C8AQ33908547-C290F2E3-F24B-425A-9B81-40EDAD6A020DQ33941012-E8E0A133-F233-4699-9F51-906841C0EA22Q34036213-515AFD9F-D285-4E51-BAAD-C3F61918605DQ34165454-E3936A86-5A33-4B6D-90A8-5D9FA7EA8009Q34182786-E5E82001-E520-4F50-BC92-AB0CB0F75DDBQ34295186-BC7609F3-894E-4826-AC47-911380061CDFQ34309388-D52DD81E-B03F-43A4-812C-949D9145A2CBQ34653719-3FBE1CF7-D44A-4F55-B4BC-23F98462A432Q34694796-D4FC16DB-DB72-4EA0-BE66-41A18FC1F039Q35029964-67FF3CD7-F6B6-4675-9B0B-ED52B3D2887BQ35059829-42B41A7B-7BC7-4338-A545-7A3A15D23924Q35202343-F159C02A-B02F-4D69-8D32-34CA8BF1F3A4Q35583414-2A613698-15F3-4B34-83B6-912B30B109BFQ35605318-D2DBD008-3A29-4D99-AC63-3FBD3278B742Q35891332-9EC70D64-ECEA-4044-B23A-EF052299BAC6Q36140986-E661EB28-8B7D-4C98-B30D-87F62B58E3BDQ36176014-6849A4E2-CEED-4068-B376-B38D57632C7FQ36429491-2D701CAD-0A98-48B7-845C-7BB65BF301D2Q36654098-9D0075A0-CC6F-4EC6-B23F-079C54A587AFQ36659242-CD04A6E8-55E4-470E-8A25-BA59F3F8C3BBQ36698269-69CBDADC-76F2-46CD-8CF6-AD1C7670F6DDQ36755385-92B5C0EF-FA9B-4EC4-9022-DC8C1B3DB0F1Q36839680-1A96DBEA-3140-4728-9C2B-F74ABF2063ADQ36915132-5DD0AAC3-508E-49F6-B1D9-36B63C3DBAB8Q36915167-89DB35B2-3917-460A-BFF0-848CCB2A78E2
P2860
Resistance of mature T cells to oncogene transformation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Resistance of mature T cells to oncogene transformation.
@en
Resistance of mature T cells to oncogene transformation.
@nl
type
label
Resistance of mature T cells to oncogene transformation.
@en
Resistance of mature T cells to oncogene transformation.
@nl
prefLabel
Resistance of mature T cells to oncogene transformation.
@en
Resistance of mature T cells to oncogene transformation.
@nl
P2093
P50
P1433
P1476
Resistance of mature T cells to oncogene transformation.
@en
P2093
Christopher Baum
Johann Meyer
Kerstin Cornils
Marianne Hartmann
Sebastian Newrzela
Sylvia Hartmann
Zhixiong Li
P304
P356
10.1182/BLOOD-2007-12-128751
P407
P577
2008-06-19T00:00:00Z